Haloperidol versus risperidone for schizophrenia

Background Schizophrenia is a disabling serious mental illness that can be chronic. Haloperidol, one of the first generation of antipsychotic drugs, is effective in the treatment of schizophrenia but can have adverse side effects. The effects of stopping haloperidol in people with schizophrenia who are stable on their prescription are not well researched in the context of systematic reviews. Objectives To review the effects of haloperidol discontinuation in people with schizophrenia who are stable on haloperidol.

show abstract

Haloperidol discontinuation for people with schizophrenia

Essali

Turkmani

Aboudamaah

et al. 2019

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

show abstract

Haloperidol versus olanzapine for people with schizophrenia

Ibragimov

Keane

Glaría

et al. 2019

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders

Ibragimov,

Keane,

Carreño Glaría

et al. 2024

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Haloperidol versus risperidone for schizophrenia

Abstract: This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To review the clinical effectiveness and safety of haloperidol compared with risperidone for people with schizophrenia.

Cited by 3 publications

References 56 publications

Haloperidol discontinuation for people with schizophrenia

Haloperidol discontinuation for people with schizophrenia

Haloperidol versus olanzapine for people with schizophrenia

Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders

Contact Info

Product

Resources

About